Roivant Sciences Ratios (2020-2025) | ROIV

Ratios Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter)
90.41%54.38%94.31%60.04%70.95%78.97%80.51%93.89%98.73%97.33%94.77%97.13%92.90%92.93%64.98%
EBT Margin (Quarter)
-1,305.56%-1,610.35%-1,257.33%-8,098.75%-2,503.44%-2,240.66%-1,508.01%-6,617.49%33,116.21%-245.81%-5,014.15%-2,600.50%-12,408.39%-10,123.74%-14,525.71%
EBIT Margin (Quarter)
-1,995.95%-4,893.32%-1,010.73%-6,536.44%-2,240.21%-2,217.20%-1,278.27%-5,863.24%32,948.56%-1,279.54%-7,636.04%-3,042.59%-13,130.05%-19,492.87%-16,966.13%
EBITDA Margin (Quarter)
-1,995.95%-4,893.32%-1,010.73%-6,536.44%-2,240.21%-2,217.20%-1,278.27%-5,863.24%32,948.56%-1,279.54%-7,636.04%-3,042.59%-13,130.05%-19,492.87%-16,966.13%
Operating Margin (Quarter)
-1,995.95%-4,893.32%-1,010.73%-6,536.44%-2,240.21%-2,217.20%-1,278.27%-5,863.24%32,948.56%-1,279.54%-7,636.04%-3,042.59%-13,130.05%-19,492.87%-16,966.13%
Net Margin (Quarter)
-1,306.76%-1,613.21%-1,257.49%-8,191.34%-2,520.71%-2,257.19%-1,516.12%-2,360.22%-376.01%1,115.06%-962.75%3,626.30%
FCF Margin (Quarter)
-1,855.32%-881.94%-2,224.37%-6,009.28%-1,537.79%-3,960.67%-1,157.67%-5,392.05%-4,227.25%-2,425.46%-5,984.40%-7,437.06%-9,604.52%-12,317.76%-9,582.24%
Efficiency
Inventory Average (Quarter)
3.49M4.57M5.07M20.25M34.62M
Assets Average (Quarter)
2,522.19M2,778.80M2,951.14M2,692.25M2,592.76M2,407.97M2,209.25M2,296.28M2,263.12M2,101.09M4,689.11M7,267.58M6,859.47M6,351.24M5,999.19M5,614.64M5,234.77M5,047.60M5,143.98M
Equity Average (Quarter)
2,105.39M1,998.43M2,192.87M2,337.84M2,143.10M1,897.17M1,634.77M1,470.64M1,517.36M1,470.86M1,329.89M3,955.11M6,516.56M6,171.91M5,737.66M5,558.01M5,111.79M4,751.76M4,810.68M4,537.36M
Invested Capital (Quarter)
2,209.79M2,143.69M2,628.28M2,451.30M2,248.97M2,139.11M1,890.21M1,802.26M1,983.10M1,719.21M1,715.08M6,987.92M6,879.12M6,207.00M5,580.04M5,535.97M4,687.60M4,815.91M4,805.46M4,269.26M
Asset Utilization Ratio (Quarter)
0.010.010.020.020.020.030.020.030.010.010.000.010.000.000.00
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-108.08-33.69-44.76-31.02-23.13542.93-7.63
Debt to Equity (Quarter)
0.080.100.080.090.020.020.130.050.120.060.060.030.030.01
Debt Ratio (Quarter)
0.070.080.060.070.010.010.090.030.080.040.040.030.030.01
Equity Ratio (Quarter)
0.790.800.780.800.790.680.680.650.670.620.640.900.890.910.900.960.860.960.950.82
Times Interest Earned (Quarter)
-108.08-33.69-44.76-31.02-23.13542.93-7.63
Valuation
Enterprise Value (Quarter)
-1891.02M-1768.49M-2480.37M-1821.37M-2041.81M-1532.67M-1249.47M-1527.44M-1232.00M-1010.68M-1031.13M-6175.99M297.28M-5240.02M-3124.42M-4800.01M-4387.30M-4032.88M-3942.71M-3825.01M
Return Ratios
Return on Sales (Quarter)
-0.13%-0.16%-0.13%-0.82%-0.25%-0.23%-0.15%-0.24%-0.04%0.11%-0.10%0.36%0.12%0.19%
Return on Capital Employed (Quarter)
-29.59%-50.68%-48.16%-60.39%-68.60%-60.42%-60.33%-62.61%97.28%68.25%77.13%77.77%-19.59%-24.57%-24.13%
Return on Invested Capital (Quarter)
0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.01%0.01%0.01%0.01%0.00%0.00%0.00%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%